PSNL

Personalis, Inc.

Healthcare · Diagnostics & Research

$217.57 sample

-0.67 (-0.31%) 1D

Market cap

$1.32T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-23

Alerts

8

Price$217.57 +18.07% 3M daily closessample

219.93184.27

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23SEC10-Q filed
Sep 17INSInsider buy: EVP, Operations
Sep 11INSInsider sell: Chief Financial Officer
Sep 08INSInsider sell: Chief Executive Officer
Sep 01INSInsider sell: Chief Financial Officer
Aug 26SEC10-Q filed
Aug 21INSInsider sell: Chief Financial Officer
Aug 12INSInsider sell: Director

Sign up to see the real PSNL record →

Company facts

SEC EDGAR registration

Name: Personalis, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: +32sample, -100 to +100
Reporting currency: USD

Who is positioning in PSNL

sample

Insiders: 11 insider transactions over 90 days, net selling, $58.6M
Congress: No member trades over 90 days
Institutions · 13F: 35 funds hold $9.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$74.9B +13.6% y/y

Q4 2024Q3 2026

Inventory$44.2B +7.8% y/y

Q4 2024Q3 2026

Accounts receivable$33.5B +7.7% y/y

Q4 2024Q3 2026

Total debt$94.8B +14.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $521.8B +8.7% 3M
Sample peer B: $441.9B +16.1% 3M
Sample peer C: $778.5B +15.8% 3M
Sample peer D: $484.6B +7.5% 3M
Sample peer E: $1.10T -10.2% 3M